| Arlene Bolorin-aquino, OTR/L | |
|
Paseo De La Ceiba Calle Areca, # 201, Juncos, PR 00777-7415 | |
| (787) 413-1687 | |
| Not Available |
| Full Name | Arlene Bolorin-aquino |
|---|---|
| Gender | Female |
| Speciality | Community Health Worker |
| Location | Paseo De La Ceiba Calle Areca, Juncos, Puerto Rico |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235307190 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 813 (Puerto Rico) | Secondary |
| 172V00000X | Community Health Worker | 813 (Puerto Rico) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Arlene Bolorin-aquino, OTR/L Paseo De La Ceiba Calle Areca, # 201, Juncos, PR 00777-7415 Ph: (787) 413-1687 | Arlene Bolorin-aquino, OTR/L Paseo De La Ceiba Calle Areca, # 201, Juncos, PR 00777-7415 Ph: (787) 413-1687 |
News Archive
Onyx Pharmaceuticals, Inc. today announced summaries of three poster presentations of single-agent carfilzomib, a next generation proteasome inhibitor, in patients with relapsed and/or refractory multiple myeloma at the 53rd American Society of Hematology (ASH) Annual Meeting in San Diego, CA.
Eli Lilly and Company and BioMS Medical Corp. have announced that the two companies have entered into a licensing and development agreement granting Lilly exclusive worldwide rights to BioMS Medical's lead multiple sclerosis (MS) compound, MBP8298.
Researchers at Mount Sinai School of Medicine have shown for the first time in an animal model that vitamin C actively protects against osteoporosis, a disease affecting large numbers of elderly women and men in which bones become brittle and can fracture. The findings are published in the October 8 online edition of PLoS ONE.
According to the latest medical discovery a protein that acts as a "master switch" has been found to determine whether certain white blood cells will boost or dampen inflammation. This may open new avenues in rheumatoid arthritis research. Rheumatoid arthritis or RA is an inflammatory disease that causes severe progressive crippling of the joints.
› Verified 4 days ago